These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 2725855)
1. The effects of chronic treatment with amitriptyline and MDL 72394 on the control of 5-HT release in vivo. Sleight AJ; Smith RJ; Marsden CA; Palfreyman MG Neuropharmacology; 1989 May; 28(5):477-80. PubMed ID: 2725855 [TBL] [Abstract][Full Text] [Related]
2. Monoamine receptor sensitivity changes following chronic administration of MDL 72394, a site-directed inhibitor of monoamine oxidase. Palfreyman MG; Mir AK; Kubina M; Middlemiss DN; Richards M; Tricklebank MD; Fozard JR Eur J Pharmacol; 1986 Oct; 130(1-2):73-89. PubMed ID: 3780861 [TBL] [Abstract][Full Text] [Related]
3. Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan. Sleight AJ; Marsden CA; Martin KF; Palfreyman MG Br J Pharmacol; 1988 Feb; 93(2):303-10. PubMed ID: 2451963 [TBL] [Abstract][Full Text] [Related]
4. Chronic MAO A and MAO B inhibition decreases the 5-HT1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase. Sleight AJ; Marsden CA; Palfreyman MG; Mir AK; Lovenberg W Eur J Pharmacol; 1988 Sep; 154(3):255-61. PubMed ID: 3234480 [TBL] [Abstract][Full Text] [Related]
5. The 5-HT1 receptor agonist RU-24969 decreases 5-hydroxytryptamine (5-HT) release and metabolism in the rat frontal cortex in vitro and in vivo. Brazell MP; Marsden CA; Nisbet AP; Routledge C Br J Pharmacol; 1985 Sep; 86(1):209-16. PubMed ID: 2413936 [TBL] [Abstract][Full Text] [Related]
6. Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex. Kihara T; Ikeda M J Pharmacol Exp Ther; 1995 Jan; 272(1):177-83. PubMed ID: 7815331 [TBL] [Abstract][Full Text] [Related]
7. Opposing roles for 5-HT1B and 5-HT3 receptors in the control of 5-HT release in rat hippocampus in vivo. Martin KF; Hannon S; Phillips I; Heal DJ Br J Pharmacol; 1992 May; 106(1):139-42. PubMed ID: 1504723 [TBL] [Abstract][Full Text] [Related]
8. The effect of SB-236057-A, a selective 5-HT1B receptor inverse agonist, on in vivo extracellular 5-HT levels in the freely-moving guinea-pig. Roberts C; Hatcher P; Hagan JJ; Austin NE; Jeffrey P; Wyman P; Gaster LM; Routledge C; Middlemiss DN Naunyn Schmiedebergs Arch Pharmacol; 2000 Aug; 362(2):177-83. PubMed ID: 10961381 [TBL] [Abstract][Full Text] [Related]
9. Identification and role of serotonin 5-HT1A and 5-HT1B receptors in primary cultures of rat embryonic rostral raphe nucleus neurons. Héry F; Boulenguez P; Sémont A; Héry M; Becquet D; Faudon M; Deprez P; Fache MP J Neurochem; 1999 May; 72(5):1791-801. PubMed ID: 10217255 [TBL] [Abstract][Full Text] [Related]
10. The putative 5-HT1B receptor agonist CP-93,129 suppresses rat hippocampal 5-HT release in vivo: comparison with RU 24969. Hjorth S; Tao R Eur J Pharmacol; 1991 Dec; 209(3):249-52. PubMed ID: 1797566 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of monoamine oxidase within monoaminergic neurons in the rat brain by (E)-beta-fluoromethylene-m-tyrosine (MDL 72394). Fagervall I; Ross SB J Neurochem; 1989 Feb; 52(2):467-71. PubMed ID: 2521360 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of monoamine oxidase selectively in brain monoamine nerves using the bioprecursor (E)-beta-fluoromethylene-m-tyrosine (MDL 72394), a substrate for aromatic L-amino acid decarboxylase. Palfreyman MG; McDonald IA; Fozard JR; Mely Y; Sleight AJ; Zreika M; Wagner J; Bey P; Lewis PJ J Neurochem; 1985 Dec; 45(6):1850-60. PubMed ID: 3840523 [TBL] [Abstract][Full Text] [Related]
14. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor. Hewton R; Salem A; Irvine RJ Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093 [TBL] [Abstract][Full Text] [Related]
15. The putative 5-HT1 receptor agonist, RU 24969, inhibits the efflux of 5-hydroxytryptamine from rat frontal cortex slices by stimulation of the 5-HT autoreceptor. Middlemiss DN J Pharm Pharmacol; 1985 Jun; 37(6):434-7. PubMed ID: 2862270 [TBL] [Abstract][Full Text] [Related]
16. Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat. Celada P; Artigas F Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):583-90. PubMed ID: 7689703 [TBL] [Abstract][Full Text] [Related]
17. Effects of local MAO inhibition in the locus coeruleus on extracellular serotonin and 5-HIAA during exposure to sensory and cardiovascular stimuli. Kaehler ST; Philippu A; Singewald N Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):187-93. PubMed ID: 10208305 [TBL] [Abstract][Full Text] [Related]
18. 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Sharp T; Bramwell SR; Grahame-Smith DG Br J Pharmacol; 1989 Feb; 96(2):283-90. PubMed ID: 2466516 [TBL] [Abstract][Full Text] [Related]
19. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats. Kato T; Dong B; Ishii K; Kinemuchi H J Neurochem; 1986 Apr; 46(4):1277-82. PubMed ID: 2419508 [TBL] [Abstract][Full Text] [Related]
20. In vivo regulation of the serotonin-2 receptor in rat brain. Stockmeier CA; Kellar KJ Life Sci; 1986 Jan; 38(2):117-27. PubMed ID: 2935693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]